Ezetimibe and Kineret drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Kineret (anakinra). Common drug interactions include poor quality sleep among females and blood testosterone increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Kineret. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Kineret?

Kineret has active ingredients of anakinra. It is often used in rheumatoid arthritis. eHealthMe is studying from 11,120 Kineret users. Check the latest studies of Kineret.

On Aug, 08, 2026

26 people who take Ezetimibe and Kineret together, and have interactions are studied.

Ezetimibe and Kineret drug interactions.

What are the common drug interactions of Ezetimibe and Kineret, by gender? *:

female:

Poor quality sleep
Impaired work ability
Contusion (a type of hematoma of tissue in which capillaries)
Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Herpes zoster
Hyperlipidaemia (presence of excess lipids in the blood)

male:

Blood testosterone increased
Dizziness
Injection site discomfort
Injection site erythema (redness at injection site)
Injection site pain
Injection site rash
Injection site reaction
Joint swelling

What are the common drug interactions of Ezetimibe and Kineret, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Poor quality sleep
Impaired work ability
Body tinea (ringworm of the body)
Bone density decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Contusion (a type of hematoma of tissue in which capillaries)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Herpes zoster
Hyperlipidaemia (presence of excess lipids in the blood)

60+:

Blood testosterone increased
Dizziness
Injection site discomfort
Injection site erythema (redness at injection site)
Injection site pain
Injection site rash
Injection site reaction
Joint swelling

What are the existing conditions these people have? *

Migraine (headache): 22 people, 84.62%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 22 people, 84.62%
Insomnia (sleeplessness): 12 people, 46.15%
Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Kineret?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously